Reverse vaccinology - In search of a genome-derived meningococcal vaccine

Vaccine

Volumn 24, Issue SUPPL. 2, 2006, Pages S11-S12

  Danzig, Lisa ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Genomic; N. meningitidis; Vaccine

Indexed keywords

MENINGOCOCCUS VACCINE;

ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; ENDEMIC DISEASE; ESCHERICHIA COLI; EXPERIMENTAL MODEL; GENOME; HUMAN; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

EID: 33645226469     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.01.103     Document Type: Article

References (11)

1. G.V.G. Sierra, H.C. Campa, N.M. Valcarcel, I.L. Garcia, P.L. Izquierdo, and P.F. Sotolongo Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba NIPH Ann 14 1991 195 210
2. G. Bjune, E.A. Høiby, J.K. Grønnesby, O. Arnesen, J.H. Fredriksen, and A. Halstensen Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway Lancet 338 1991 1093 1096
3. J.W. Tappero, R. Lagos, A.M. Ballesteros, B. Plikaytis, D. Williams, and J. Dykes Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile JAMA 281 16 1999 1520 1527
4. B. Capecchi, D. Serruto, J. Adu-Bobie, R. Rappuoli, and M. Pizza The genome revolution in vaccine research Curr Issues Mol Biol 6 1 2004 17 27
5. M. Pizza, V. Scarlato, V. Masignani, M.M. Giuliani, B. Arico, and M. Comanducci Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing Science 287 5459 2000 1816 1820
6. M. Comanducci, S. Bambini, B. Brunelli, J. Adu-Bobie, B. Arico, and B. Capecchi NadA, a novel vaccine candidate of Neisseria meningitidis J Exp Med 195 11 2002 1445 1454
7. D. Serruto, J. Adu-Bobie, M. Scarselli, D. Veggi, M. Pizza, and R. Rappuoli Neisseria meningitidis App, a new adhesin with autocatalytic serine protease activity Mol Microbiol 48 2 2003 323 334
8. J.A. Welsch, G.R. Moe, R. Rossi, J. Adu-Bobie, R. Rappuoli, and D.M. Granoff Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity J Infect Dis 188 11 2003 1730 1740
9. D.M. Granoff, G.R. Moe, M.M. Giuliani, J. Adu-Bobie, L. Santini, and B. Brunelli A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis J Immunol 167 11 2001 6487 6496
10. V. Masignani, E. Balducci, F. Di Marcello, S. Savino, D. Serruto, and D. Veggi NarE: a novel ADP-ribosyltransferase from Neisseria meningitidis Mol Microbiol 50 3 2003 1055 1067
11. V. Masignani, M. Comanducci, M.M. Giuliani, S. Bambini, J. Adu-Bobie, and B. Arico Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870 J Exp Med 197 6 2003 789 799